{"id":"W2979365039","doi":"10.1182/blood.v106.11.2977.2977","title":"A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Fludarabine; Medicine; Chronic lymphocytic leukemia; Internal medicine; Gastroenterology; Cancer; CD5; Leukemia; Oncology; Immunology; Chemotherapy; Lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002049125,0.001282912,0.001595267,0.0004367174,0.0007842616,0.0008336357,0.0008464947,0.00112258,0.00605528],"category_scores_gemma":[0.000796446,0.0004653736,0.0005412427,0.0008229312,0.0007611557,0.0003324534,0.0002848754,0.002204018,0.001111255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002606881,"about_ca_system_score_gemma":0.005854857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03439698,"about_ca_topic_score_gemma":0.09444646,"domain_scores_codex":[0.9995037,0.0002414412,0.00002012358,0.00005391197,0.00007204325,0.0001086522],"domain_scores_gemma":[0.9994253,0.00006725307,0.0000758674,0.00003710219,0.00007268677,0.0003218688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7094033,0.05099951,0.02444877,0.002103528,0.001507641,0.0008248333,0.0004391899,0.002145367,0.02965115,0.0007783105,0.04142534,0.136273],"study_design_scores_gemma":[0.7803771,0.1496753,0.04671708,0.0001458863,0.0005780408,0.0004015261,0.00008729129,0.0007655149,0.002146699,0.0001904313,0.01888094,0.00003404082],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9294312,0.009575175,0.0008208895,0.002201408,0.0003618552,0.02809966,0.01511263,0.0001874182,0.01420979],"genre_scores_gemma":[0.9243683,0.007400229,0.004866734,0.00546161,0.0004286391,0.01938759,0.0197387,0.00006991725,0.01827834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03439698,"threshold_uncertainty_score":0.06839353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08770439753966136,"score_gpt":0.4259201584708719,"score_spread":0.3382157609312106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}